Results 81 to 90 of about 1,789 (171)
Vaginal Formulations for Prevention of Sexual Transmission of HIV [PDF]
, 2018 According to UNAIDS, as there is still no effective vaccine against HIV, pre-exposure prophylasis (PrEP) is necessary to reduce its incidence. Sexual transmission rate is higher from men to women in developing countries and vertical transmission may also
Cazorla-Luna, Raúl +4 more
core +2 more sources
Vaginal rings for delivery of HIV microbicides
International Journal of Women's Health, 2012 R Karl Malcolm, Susan M Fetherston, Clare F McCoy, Peter Boyd, Ian MajorSchool of Pharmacy, Queen's University Belfast, Belfast, UKAbstract: Following the successful development of long-acting steroid-releasing vaginal ring devices for the ...
McCoy CF +4 more
doaj
Highlights from the 9th IAS conference on HIV science, 23-26 July 2017, Paris, France [PDF]
, 2017 The 9th International AIDS Society Conference on HIV Science (IAS 2017) took place at the Palais des Congrès, in Paris, France, from 23 to 26 July 2017, chaired by Linda-Gail Bekker and Jean-François Delfraissy. It was organised by the International AIDS
Barber, Tristan J +3 more
core +2 more sources
Viruses, 2014 Nonnucleoside reverse transcriptase inhibitors (NNRTIs) are widely used to treat HIV-1-infected individuals; indeed most first-line antiretroviral therapies typically include one NNRTI in combination with two nucleoside analogs.
Nicolas Sluis-Cremer
doaj +1 more source
Journal of the International AIDS Society, 2023 Introduction The burden of HIV in sub‐Saharan Africa (SSA) remains unacceptably high, and disproportionately affects girls and women. While the introduction of oral HIV pre‐exposure prophylaxis (PrEP) in 2012 revolutionized HIV prevention, its ...
Nyaradzo M. Mgodi +6 more
doaj +1 more source
Frontiers in Reproductive Health, 2021 Background: Robust data summarizing the prevalence of pregnancy and neonatal outcomes in low- and middle-income countries are critically important for studies evaluating investigational products for HIV prevention and treatment in pregnant and ...
Erica M. Lokken +9 more
doaj +1 more source
CCR5 antagonists used as topical microbicides modulate CCR5 expression and may potentially compound HIV infection [PDF]
, 2017 CCR5 antagonists, such as Maraviroc (MVC) and 5P12-RANTES, are being evaluated as HIV preventatives. The advantage of these drugs is that they restrict HIV entry via CCR5 receptor.
Laux, Julie
core
Coming of age? Women's sexual and reproductive health after twenty-one years of democracy in South Africa [PDF]
, 2016 This paper is a sequel to a 2004 article thet reviewed South Africa's introduction of new sexual and reproductive health (SRH) and rights, laws, policies and programmes, a decade into democracy. Similarly to the previous article this paper focuses on key
Constant, D. +7 more
core +1 more source
In Vitro Methods for Evaluating Drug Release of Vaginal Ring Formulations—A Critical Review [PDF]
, 2019 The vagina is a promising site for both local and systemic drug delivery and represents an interesting administration route for compounds with poor oral bioavailability.
Klein, Sandra, Tietz, Katharina
core +1 more source
A model of HIV/AIDS population dynamics including ARV treatment and pre-exposure prophylaxis [PDF]
, 2018 Antiretroviral treatment (ART) and oral pre-exposure prophylaxis (PrEP) have recently been used efficiently in management of HIV infection. Pre-exposure prophylaxis consists in the use of an antiretroviral medication to prevent the acquisition of HIV ...
CP Bhunu +18 more
core +2 more sources